Mylan scores multiple sclerosis patent win over Biogen

23-06-2020

Mylan scores multiple sclerosis patent win over Biogen

PictureDesignSwiss / Shutterstock.com

Mylan has succeeded in having a key Biogen patent covering multiple sclerosis (MS) drug Tecfidera (dimethyl fumarate) invalidated by a US federal court.


Mulan, Biogen, Tecfidera, patent, specification, Western Virginia, district court, dimethyl fumarate, multiple sclerosis, MS

LSIPR